Abstract
Background The COVID-19 pandemic poses an unprecedented threat to the health and economic prosperity of the world’s population. Yet, some countries or regions within a country appear to be affected in different ways.
Objectives This research aims to understand whether the outbreak varies significantly between U.S. states and counties.
Methods A statistical model is estimated using publicly available outbreak data in the U.S., and regional differences are statistically analyzed.
Results There is significant variance in outbreak data between U.S. states and counties. At the state level, the outbreak rate follows a normal distribution with an average relative growth rate of 0.197 (doubling time 3.518 days). But there is a low degree of reliability between state-wide and county-specific data reported (ICC = 0.169, p < 0.001), with a bias of 0.070 (standard deviation 0.062) as shown with a Bland-Altman plot.
Conclusions The results emphasize the need for policy makers to look at the pandemic from the smallest population subdivision possible, so that countermeasures can be implemented, and critical resources provided effectively. Further research is needed to understand the reasons for these regional differences.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We gratefully acknowledge support through the Darla Moore School of Business and the Center for International Business Education and Research (CIBER) at the University of South Carolina.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The original data sources are referenced in the section Model and methods.
